Adaptimmune Therapeutics
ADAP
#9325
Rank
โ‚ฌ60.56 M
Marketcap
0,24ย โ‚ฌ
Share price
-20.31%
Change (1 day)
-81.10%
Change (1 year)

Market capitalization of Adaptimmune Therapeutics (ADAP)

Market cap: โ‚ฌ60.56 Million

As of April 2025 Adaptimmune Therapeutics has a market cap of โ‚ฌ60.56 Million. This makes Adaptimmune Therapeutics the world's 9325th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptimmune Therapeutics from 2015 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ60.56 M-58.26%
2024โ‚ฌ0.14 B-10.95%
2023โ‚ฌ0.16 B-26.93%
2022โ‚ฌ0.22 B-56.89%
2021โ‚ฌ0.51 B-23.75%
2020โ‚ฌ0.67 B502.12%
2019โ‚ฌ0.11 B-78.57%
2018โ‚ฌ0.52 B0.77%
2017โ‚ฌ0.52 B91.37%
2016โ‚ฌ0.27 B-65.09%
2015โ‚ฌ0.78 B

End of Day market cap according to different sources

On Apr 4th, 2025 the market cap of Adaptimmune Therapeutics was reported to be:

โ‚ฌ0.36 Billion
by Nasdaq info icon info icon
โ‚ฌ60.56 Million
by CompaniesMarketCap info icon info icon
โ‚ฌ60.56 Million
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚ฌ0.91 B 1,411.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ13.86 M-77.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.44 B 629.80%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚ฌ8.82 B 14,473.36%๐Ÿ‡บ๐Ÿ‡ธ USA